Cytosorbents
CTSO
#9904
Rank
NZ$65.69 M
Marketcap
NZ$1.05
Share price
-4.43%
Change (1 day)
-41.74%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -NZ$22.55 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$36.97 Million. In 2024 the company made an earning of -NZ$37.74 Million, an increase over its 2023 earnings that were of -NZ$48.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$22.55 Million-40.24%
2024 -NZ$37.74 Million-22.49%
2023 -NZ$48.69 Million-13.52%
2022 -NZ$56.3 Million34.04%
2021 -NZ$42 Million182.17%
2020 -NZ$14.89 Million-55.97%
2019 -NZ$33.81 Million14.17%
2018 -NZ$29.61 Million95.14%
2017 -NZ$15.18 Million-22.32%
2016 -NZ$19.54 Million39.1%
2015 -NZ$14.05 Million-12.89%
2014 -NZ$16.12 Million89%
2013 -NZ$8.53 Million26.65%
2012 -NZ$6.74 Million-26.02%
2011 -NZ$9.11 Million-288.45%
2010 NZ$4.82 M-4.17%
2009 NZ$5.04 M-287.19%
2008 -NZ$2.7 Million-47.12%
2007 -NZ$5.1 Million41.78%
2006 -NZ$3.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$5.42 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.32 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
NZ$92.16 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA